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ABSTRACT
Protein recycling is an essential cellular process that involves endocytosis, intracellular
trafficking, and exocytosis. In mammalian systems, membrane lipids (including
cholesterol, sphingolipids, and phospholipids) play a pivotal role in protein recycling. To
address this role in budding yeast, Saccharomyces cerevisiae, I utilized GFP-Snc1, a
fluorescent marker for reporting the recycling pathway. Moderate to significant GFPSnc1 recycling defects occurred upon overexpression or inactivation of phospholipid,
ergosterol, and sphingolipid biosynthesis enzymes, indicating that homeostasis of
membrane lipid levels is prerequisite for proper protein recycling. Expression of a
truncated version of GFP-Snc1 that cannot be recycled from the plasma membrane
revealed that abnormalities in Snc1 localization in membrane lipid overexpression or
underexpression mutants are not due to defects in the synthetic/secretory pathway, but
rather in the intracellular trafficking pathway. Membrane lipid imbalance resulted in an
accumulation of the late endosome marker Vps10-GFP, indicating trafficking from the
endosomes to the Golgi may be being hindered, preventing recycling to the plasma
membrane. To elucidate the possible mechanism for this trafficking hindrance, I stained
the actin cytoskeleton, then quantified the percentage of cells with visible actin cables.
Compared to wild-type cells, membrane lipid mutant cells exhibited lower levels of actin
cables, indicating the actin cytoskeleton is disrupted upon membrane lipid imbalance.
Taken together, my results show that impairment of proper recycling may be due to
disruption of the actin cytoskeleton, which causes trafficking hindrance between the
endosomes and Golgi.
KEYWORDS: protein recycling, endocytosis, yeast, intracellular trafficking, Snc1,
actin, cell biology
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INTRODUCTION

Importance of Recycling in Human Cells
The ability to recycle various components, including proteins and membrane
materials, is essential for maintaining cellular health. Rather than having to synthesize
these elements de novo each time, recycling allows for the conservation of energy,
enabling the cell to grow more rapidly, without the waste that would arise from
discarding still-functional intracellular machinery. Defects in various recycling pathways
can cause defects on a cellular level. For example, blockage of claudin-1 recycling in
epithelial cells prevents proper formation of the epithelial barrier (Dukes et al., 2012),
and inhibition of recycling can cause improper protein accumulation at the endoplasmic
reticulum and Golgi body (Fujiwara et al., 1998; Storrie, 2005). On a systemic level,
improper protein recycling has been implicated in a variety of neurodegenerative
diseases, including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and
Alzheimer's disease (Fecto et al., 2014). When recycling is disrupted, protein aggregates
can form, interfering with proper neuronal function and leading to a disease state
(Douglas and Dillin, 2010).
The prominent hallmark of Alzheimer’s disease is the accumulation of amyloid β
plaques within the brain, which can lead to hypometabolism within the prefrontal portion
of the brain (Klupp et al., 2015). This accumulation is the result of improper protein
trafficking and recycling within the cell. Specifically, defects in the function of the
retromer complex, which mediates the movement of recycled proteins from the
endosomes to the Golgi, have been implicated in the Alzheimer’s disease process (Wang

1

and Bellen, 2015). Additionally, modifications to the COPI complex, which coats
vesicles during retrograde transport from the Golgi to the endoplasmic reticulum, have
been shown to impact the localization and accumulation of amyloid β plaques (Bettayeb
et al., 2016). Taken together, these recycling defects cause problems in cognitive function
for the estimated 5.4 million Americans currently suffering from Alzheimer’s disease
(Alzheimer's, 2016).
Recycling defects have also been implicated in Parkinson’s disease, a
neurodegenerative disease characterized by slowing and/or difficulty in moving, tremors,
and balance and postural instability (Csoti et al., 2016; Fecto et al., 2014). During the
progression of Parkinson’s disease, α synuclein, which normally plays a role in the
function of neurons and in the stress response, forms aggregates called Lewy bodies
(Benskey et al., 2016). Mutations in the VPS35 component of the retromer complex have
been associated with Parkinson’s disease (Wang et al., 2016). These mutations have been
shown to inhibit protein-protein interactions, leading to defects in endosome-Golgi
recycling traffic, which may play a role in aggregate formation (McGough et al., 2014).
Additionally, the small GTPases Rab11a and Rab13, which play roles in intracellular
trafficking, have been found to promote clearance of α synuclein, and defects in steps
mediated by these two proteins could lead to aggregate formation (Goncalves and
Outeiro, 2016).
A greater understanding of the mechanisms of protein and membrane recycling
will help shed light on possible biomedical and therapeutic targets, which will enable
better management of diseases caused by recycling defects. Therefore, this introduction
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will focus on the in-depth process of protein recycling, particularly retrograde (endosome
to Golgi) trafficking, and the effects of altered membrane dynamics on this process.

General Recycling Information
Among eukaryotic systems, the budding yeast Saccharomyces cerevisiae is one of
the most well-studied models for the recycling pathway, owing to its ease of culture,
genetic manipulability, and similarity to higher eukaryotic systems (Feyder et al., 2015).
Through observation of the phenotypes of genetically modified strains, coupled with liveimaging, immunofluorescent staining (Keil and Hatzfeld, 2014), creation of pointmutations, fluorescent tagging (Schafer et al., 2016), and using monoclonal antibodies to
label embedded membrane proteins (Blagojevic Zagorac et al., 2017), a detailed map of
the recycling pathway has been constructed, along with determination of the major
proteins involved in each step (Amberg et al., 2005; Blagojevic Zagorac et al., 2017).
Recycling of embedded membrane proteins begins with endocytosis at the section
of the plasma membrane containing the proteins to be recycled. With the help of various
protein complexes, a portion of the plasma membrane starts to curve inward, forming an
invaginated pit, which is then pinched off to form a vesicle that contains the proteins to
be recycled embedded in its membrane (Idrissi and Geli, 2014). From here, proteins can
go through three possible routes. Multiple endocytosed vesicles fuse to form sorting or
early endosomes, which can then recycle proteins through the first (“fast”) recycling
pathway, directly back to the plasma membrane, or send proteins along a second (“slow”)
recycling pathway, through sorting endosomes, and then back to the plasma membrane
(Furuta et al., 2007; Lock and Stow, 2005). A third (retrograde) recycling pathway
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involves retrograde trafficking of proteins from the endosomes to the trans-Golgi network
(TGN), followed by recycling back to the plasma membrane through the secretory
pathway (Burd, 2011).
Many proteins and protein complexes are important in the recycling process.
During endocytosis, the adaptor protein complex AP2 either associates directly with
phosphatidylinositol (4,5)-bisphosphate (PIP2) present in the cell membrane, or is
recruited via interaction with the cytoplasmic portions of receptor proteins embedded in
the membrane (Robinson, 2004; Sorkin, 2004). The presence of AP2 allows the coat
protein clathrin to be recruited to the plasma membrane, followed by binding of a variety
of cargo proteins, which will be carried within the budding vesicle, to the embedded
receptor proteins (Idrissi et al., 2008). Association of epsin/Ent1 with lipids in the
clathrin-coated membrane permits recruitment of late coat proteins, which in turn
promote actin association and polymerization, which causes invagination of the
membrane (Fernandez-Golbano et al., 2014; Sen et al., 2012). Pinching off of the budded
vesicle occurs through membrane remodeling promoted by the SH3 and F-BAR domains
of amphiphysin/Rvs167 (Stanishneva-Konovalova et al., 2016), along with the action of
the GTPase dynamin/Vps1, which wraps around the neck of the invaginating vesicle and
constricts it, resulting in fission (Idrissi and Geli, 2014).
Once the vesicles have been pinched off, they move away from the plasma
membrane, toward early endosomes via a yet-unknown mechanism that is likely
associated with actin fibers (Toshima et al., 2016). Once at the early endosomes, proteins
are sorted to the recycling or retrograde pathways through the action of the retromer
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complex (Varandas et al., 2016). This complex contains a three-protein core called the
cargo recognition complex (CRC) which associates with various sorting nexin proteins
that determine the ultimate destination of proteins sorted by the retromer (Burd and
Cullen, 2014). Association with the sorting nexin Snx3 promotes cargo recycling directly
back to the plasma membrane, while Snx27 shifts cargo transport to the retrograde
pathway toward the TGN (Harterink et al., 2011). Vesicles are transported along
microtubule (or possibly actin) fibers to the TGN, where docking and fusion can occur,
through the action of v- and t-SNARE proteins, and possibly mediated by the Golgiassociated retrograde protein (GARP) complex (Chen et al., 2016b; Perez-Victoria et al.,
2008). Once delivered to the TGN, proteins can then be sent back to the plasma
membrane via the secretory pathway (Burd, 2011).
During intracellular trafficking, vesicles are carried to their target destinations by
a variety of motor proteins, including kinesins, dyneins, and non-muscle myosins
(Cheney and Baker, 1999; Hirokawa, 1998). Motor proteins attach to the vesicles they are
carrying, and then hydrolyze ATP to generate energy “walk” along cytoskeletal fibers
(microtubules in the case of kinesins and dyneins, and actin cables in the case of
myosins) to the target location within the cell (Foth et al., 2006). Actin cables play a
particularly important role in growth and cell division, because the formins Bnr1 and
Bni1 polymerize actin cables, allowing myosin II and V to deliver materials and
organelles, such as mitochondria, to the areas of growth (Gao and Bretscher, 2009; Lo
Presti et al., 2012). Additionally, myosin V has been shown to bind to secretory vesicles
and transport them along actin cables toward the site of exocytosis (Schott et al., 1999).
Due to actin’s role as a track for motor proteins, defects in the actin cytoskeleton are
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likely to inhibit vesicular transport and thus impede intracellular trafficking and
recycling.
One prominent example of retrograde trafficking is the yeast v-SNARE Snc1,
which functions to mediate fusion of outgoing (secretory) vesicles with the plasma
membrane, and is commonly used as a reporter for the retrograde trafficking pathway.
Snc1 is localized to the plasma membrane, with wild-type cells exhibiting a polarized
phenotype with the majority of the Snc1 being found at the growing daughter bud, where
the largest amount of secretory vesicle fusion is occurring (TerBush et al., 1996).
Because Snc1 is internalized during the endocytosis process, trafficked via the retrograde
pathway through the endosomes and TGN, and then back to the plasma membrane, the
polarized plasma membrane phenotype of Snc1 serves as an indicator that the retrograde
trafficking process is functioning normally (Wiederkehr et al., 2000).
Various proteins can be used as important markers within the retrograde pathway.
In yeast, a second example of a protein that undergoes retrograde trafficking is the
carboxypeptidase Y (CPY) receptor Vps10, which normally cycles between the
endosomes and Golgi, performing its role in sorting and trafficking CPY (Marcusson et
al., 1994). When fluorescently tagged, Vps10 serves as a good indicator of proper
retrograde (endosome-to-Golgi) traffic, since defects in this portion of the pathway will
result in Vps10 accumulation in the endosomes or misdirection to the vacuolar rim
(Marcusson et al., 1994). Carboxypeptidase Y (CPY) is the ligand of Vps10, and
normally binds to Vp10 in the Golgi and is trafficked to the endosomes, where it
dissociates from Vps10 and is then sent to the vacuole (Cereghino et al., 1995; Cooper
and Stevens, 1996). CPY itself can be used as an indicator of proper anterograde (Golgi-
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to-endosome) traffic, as missorted CPY will be secreted from the cell, while properly
sorted CPY will remain inside the cell (Jorgensen et al., 1999; Stolz and Wolf, 2012). In
mammalian cells, mannose-6-phosphate (Man6P) receptor can be used for the same
purpose as Vps10 in yeast, as a marker of proper endosome to Golgi traffic (Brown et al.,
1986).

Lipids in the Cell
Lipids are a diverse class of nonpolar or semipolar organic molecules that, in
contrast to nucleic acids and carbohydrates, are insoluble in water but soluble in nonpolar
organic solvents (Fahy et al., 2009). Within the cell, lipids have many roles, including
signaling, structural composition of membranes, and energy storage (Klug and Daum,
2014). Lipids can be synthesized de novo, or can betaken up from the environment, and
used either directly or after modification (Tehlivets et al., 2007).
The membranes that form the outer boundary of the cell and the limits of
organelles are made of three main categories of lipids: phospholipids, sphingolipids, and
sterols (cholesterol, or the yeast alternative, ergosterol) (van Meer et al., 2008). Within
each of these broad groupings; however, there are many molecular alterations that result
in a wide range of different lipids that behave in diverse ways and at various intracellular
locations. Furthermore, cells alter the lipid composition within their membranes, based on
the environment, in order to achieve optimal membrane performance (Martin et al.,
2007).
Molecules in the first category of membrane lipids, phospholipids, consist of two
fatty acid tails and a polar head group attached to a 3-carbon glycerol backbone. An
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extremely large number of different molecules with different physical properties can be
formed within the phospholipid family by varying the length and degree of saturation of
the fatty acid tails, or the molecular structure of the head group (Daum et al., 1998).
Important lipids in this family include phosphatidylinositol (PI), an important precursor
to several other phospholipids found within membranes throughout the cell (DeanJohnson and Henry, 1989; Nikawa et al., 1991). These downstream lipids include
phosphatidylinositol phosphate [PI(4)P], which is important in yeast for secretion and in
mammalian cells for recruitment of the adaptor protein AP-1 to the Golgi (Wang et al.,
2003). In addition, phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P2] is a phospholipid
that has important roles at the plasma membrane by modulatating actin polymerization
and vesicle formation (Doughman et al., 2003), and additionally playing a role in
signaling and cold tolerance (Corcoles-Saez et al., 2016). PI(4,5)P2 is synthesized
through the action of the lipid kinase Mss4 (Audhya and Emr, 2003), and can be
dephosphorylated back to PI(4)P or PI, through the action of the phosphatases Sjl1, Sjl2,
and Sjl3 (also known as Inp51, Inp52, and Inp53), thus modulating the composition of
each species of phospholipid in the membrane (Guo et al., 1999). PIP2 levels can be
synthetically depleted using a temperature sensitive mutant, mss4ts, grown at elevated
temperatures (Audhya and Emr, 2003). Additionally, accumulation of PIP2 can be
induced through deletion of SJL1, SJL2, or SJL3 (Guo et al., 1999).
Phospholipids play important roles nutritionally in brain development
(Hellhammer et al., 2010; Liu et al., 2014), as well as possibly playing roles in proper
brain function and in the prevention of neurodegenerative diseases (Nagai, 2012;
Schipper et al., 2016). Phosopholipid consumption has also been linked to resistance
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against certain kinds of bacteria and viruses (Fuller et al., 2013; Veereman-Wauters et al.,
2012). Interestingly, certain kinds of phospholipids have also been found to have antiproliferative properties, leading to speculation about the possible applications for lipids in
cancer therapies (Castro-Gomez et al., 2016; Kuchta-Noctor et al., 2016).
The second category of membrane lipids, sphingolipids, is composed of the long
chain base (a long carbon chain that terminates in an amine group and several hydroxyl
groups) parent molecule sphingosine, as well as its derivatives: ceramides,
sphingomyelins, cerebrosides, and gangliosides (Schneiter, 1999). Sphingolipids are
important parts of cell membranes, but also have signaling roles via regulating various
aspects of the yeast cell cycle from cell division through apoptosis (Spincemaille et al.,
2014). Additionally, sphingolipids have been shown to play a role in mitochondrial
function and gene expression (Kitagaki et al., 2009; Kitagaki et al., 2007). The first step
in sphingolipid production is mediated by Lcb1 and Lcb2, which together form the serine
palmitoyltransferase complex (Buede et al., 1991; Nagiec et al., 1994). This step can be
inhibited through addition of the atypical amino acid myriocin, resulting in a dosedependent depletion of sphingolipids within the treated cells (Miyake et al., 1995).
Sphingolipids have been found to have various roles in signaling and regulation of
cellular processes. Specifically, sphingolipids play a role in regulating the cell cycle,
apoptosis, cell survival (Garcia-Gil et al., 2017; Ng et al., 2017), and inflammation
(Gualtierotti et al., 2017; Ueda, 2017). Some examples of sphingolipids as signaling
molecules include their role in regulating survival and apoptosis of murine neuroblasts
(Bruno et al., 2017), and their postulated role in development of diabetes through
contributing to apoptosis of pancreatic β-cells (Ng et al., 2017). Sphingolipids also have a

9

role in recycling of endocytic membranes (Lima et al., 2017), and in intracellular
trafficking during the life cycle of some viruses, including hepatitis B and C viruses
(Zhang et al., 2016). Overall, sphingolipids play important roles as biological signaling
molecules, and their imbalance would be likely to cause defects in cell function.
Molecules in the third category of membrane lipids, sterols, have a characteristic
pattern of four interlocking hydrocarbon rings, rather than the long hydrocarbon chains
present in phospholipids and sphingolipids. Sterols interact with sphingolipids in the cell
membrane, playing an important role in endocytosis, transport of amino acids throughout
the cell, energy production, and maintenance of membrane stability during cellular stress
(Dupont et al., 2011; Parks et al., 1995; Pichler and Riezman, 2004). Among the multiple
sterols known to play important roles within the cell, cholesterol and ergosterol are the
most prominent in mammalian and yeast cells, respectively (Ikonen and Jansen, 2008).
Ergosterol is similar to cholesterol but has a slightly altered structure and
function, and is synthesized from its precursor, zymosterol, via a complex multi-step
process involving the ERG genes (Zinser et al., 1993). Knockout or overexpression of
these genes can result in an accumulation of the ergosterol precursors or ergosterol within
the cell membrane, altering cellular behavior and function (Barton et al., 1974). The final
steps of ergosterol synthesis are catalyzed by ERG6, ERG2, ERG3, ERG5, and ERG4,
and knockout of these genes results in cells that are viable, but have abnormal phenotypes
of varying degrees of severity due to the accumulation of ergosterol precursors (Lees et
al., 1995). Of these five genes, ERG6, ERG3, and ERG4 have the greatest impact on cell
physiology. In strains with any of these genes deleted, plasma membrane stability is
compromised, resulting in increased sensitivity to changes in environmental water (erg6Δ
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cells), decreased ability of the cell to maintain membrane potential (erg6Δ and erg4Δ
cells), variations in size and morphology (erg4Δ cells), and altered susceptibility to
antifungal agents (erg6Δ, erg3Δ, and erg4Δ cells) (Dupont et al., 2011; Kodedova and
Sychrova, 2015).
Cholesterol (ergosterol) has important roles in many membranes, as well as being
important as a precursor of steroid hormones (Garcia-Ruiz et al., 2016). During the
steroid synthesis process, cholesterol is encorporated into lipid droplets present in the
cytoplasm, then trafficked to the mitochondria by SNARE proteins (Kraemer et al.,
2017). The concentration of cholesterol in various organelles has been shown to be
important in the trafficking of African swine flu virus, (Cuesta-Geijo et al., 2015), and
trafficking of hedgehog ligands, which are important in the regulation of developmental
processes (Chen et al., 2016a), and integrins, which are important for interaction of cells
with the extra-cellular matrix (Garcia-Melero et al., 2016). Improper accumulation of
cholesterol in the mitochondria has been one factor implicated in the ability of cells to
avoid apoptosis, leading to cancer (Garcia-Ruiz et al., 2016; Ribas et al., 2016).
Alteration of membrane lipid concentrations is known to play a role in a variety of
diseases. For example, in mouse models of cystic fibrosis, membrane lipid imbalance was
found in affected organs, but administration of docosahexaenoic acid (Ng et al.) remedied
both the lipid imbalances and disease pathology (Freedman et al., 1999). Additionally,
alterations in lipid concentration have been found to play a role in amyloid formation,
which can contribute to damage of pancreatic β-cells, leading to type 2 diabetes (Zhang et
al., 2017) or to the death of neurons, leading to Alzheimer’s disease (Brown and Bevan,
2017). Furthermore, alterations of membrane lipids have been implicated in multiple
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sclerosis and in the progressive neurodegenerative condition Niemann-Pick C Disease,
suggesting that lipid imbalance is toxic for neural cells (Hon et al., 2009; Vance, 2006).
Altered membrane lipid concentration has been reported in other diseases,
although the imbalance may be a result, rather than a cause, of the disease. One of these
findings is that levels of cholesterol and unsaturated fatty acids increased in the
membranes of platelets isolated from women with preeclampsia (Garzetti et al., 1993).
Patients with sickle cell anemia were found to have a lack of eicosapentaenoic acid
(EPA) and docosahexaenoic acid (Ng et al.) making up the membranes of their
erythrocytes, and supplementation of EPA and DHA has been proposed as a therapy to
reduce the severity of the anemia in these patients (Connor et al., 1997; Ren et al., 2005).
Additionally, membrane lipid imbalance, specifically in immune cells such as
macrophages, has been proposed to be involved in the development of atherosclerosis
(Schmitz and Grandl, 2008).
At the cellular level, membrane lipids play an important role, especially at the
plasma membrane. Lipids are important for determining the curvature of the membrane,
which may influence interactions with nearby cells (Kuypers, 2007), as well as impacting
the secondary structure of proteins that interact with the membrane from outside the cell
(Mishig-Ochir et al., 2016). Membrane lipid imbalance can also disrupt proper
functioning of membrane proteins, including G protein-coupled receptors (GPCRs),
because proteins that are embedded in the membrane interact with membrane lipid
components (Marino et al., 2016).
Although the role of lipids in some aspects of cellular physiology, such as in
endocytosis, is well studied, potential impacts of lipid imbalance on intracellular
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retrograde trafficking is not fully understood. In mammalian cells, cholesterol depletion
has been found to interfere with trafficking of integrins, which are important in cell
adhesion to the extracellular matrix, leading to altered cell migration abilities (Reverter et
al., 2014). Furthermore, cholesterol imbalance results in mislocalization of t-SNAREs
that are important in the exocytic process, while restoration of proper cholesterol levels
restores proper exocytic trafficking (Reverter et al., 2011). Additionally, since the
concentration of membrane lipids determines proper vesicle trafficking (Johansen et al.,
2012), it is not surprising that depletion of sphingolipids in yeast results in improper
targeting of the v-SNARE Snc1 (Tani and Kuge, 2012). Since lipid imbalance is
characteristic of diseases such as Alzheimer’s, Niemann-Pick type C Disease, and
cardiovascular disease (Ikonen and Holtta-Vuori, 2004), a deeper understanding of the
role of lipids within the cell, particularly in retrograde protein trafficking, is crucial. Since
S. cerevisiae is eukaryotic and has protein trafficking similar to that of mammalian cells,
it can be used to study membrane lipid dynamics and their relationship to retrograde
protein trafficking, and potentially shed light on the mechanisms of diseases involving
membrane lipid imbalance.

Problem Statement and Conclusions
My study had two major aims. Firstly, I wanted to determine the role of the three
categories of membrane lipids (phospholipids, sphingolipids, and ergosterol) in proper
protein recycling, primarily using the recycling marker GFP-Snc1. Secondly, I sought to
investigate the mechanistic reason for recycling defects in membrane lipid imbalance
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cases. To address these goals, I used a variety of techniques including cloning, confocal
microscopy, and cell staining.
Here I present evidence that lipid homeostasis is required for proper retrograde
trafficking of proteins from the endosomes to the Golgi, in order for recycling back to the
plasma membrane through the secretory pathway. Furthermore, membrane lipid
imbalance likely contributes to retrograde trafficking defects from the early and late
endosomes to the Golgi, through disrupting actin cable formation, which is essential for
retrograde vesicular trafficking.
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MATERIALS AND METHODS

Plasmid Generation and Isolation
Yeast genomic DNA was isolated from wild type yeast (KKY 0002, Table 1)
using epicenter® MasterPure™ Yeast DNA Purification Kit (Cat No. MC85200). E. coli
HST08 cultures containing the plasmid pRS314 TEF (KKD 293, Table 2) were grown
overnight on Luria Broth (LB) plates supplemented with ampicillin. An individual colony
was used to inoculate a 3 ml culture of LB, supplemented with ampicillin to a final
concentration of 100 µg/ml. The plasmid was isolated from the 3 ml culture using
QIAprep Spin Miniprep Kit (Cat No./ID: 27106), following the protocol provided in the
kit, with elution being performed using PCR-grade water. Plasmid concentration was
determined using nanodrop equipment, then run on a 1% agarose gel to verify expected
plasmid size.
The Golgi marker Gga1 DNA sequence was copied from the template DNA using
Phusion® Green High-Fidelity DNA Polymerase Kit (Thermo Scientific™, Cat. No.
F534L) and primers KKP726 and KKP797 (Table 3), following the protocol provided by
the manufacturer. Initial denaturation was performed at 98 °C for 2 minutes, followed by
34 cycles of denaturation at 98 °C for 10 seconds, annealing at 63 °C for 30 seconds, and
extension at 72 °C for 52 seconds (1.7 kb at 30 seconds/kb). Final extension was
performed at 72 °C for 7 minutes. A portion of the PCR reaction then was run on a 1%
agarose gel to verify amplification. The PCR product was purified using Macherey Nagel
NucleoSpin® Gel and PCR Clean-up kit (Ref. No. 740609.250), and the PCR product
and vector were digested using Not1 and BamHI FastDigest Enzymes (Thermo
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Scientific™, Cat. No. FD0055 and FD0594) for 60 minutes at 37 °C, followed by thermal
inactivation for 15 minutes at 85 °C. The resulting digest was run on a 1% agarose gel,
then gel purification was performed using the previously mentioned kit. The vector and
insert were ligated at 16 °C for 16 hours. Stellar™ Competent Cells (Clontech, Cat. No.
636766) were transformed with the ligated vector, following the protocol provided by the
company. Colonies were checked via colony PCR to verify Gga1 insertion.
Gga1 was C-terminally tagged with mRFP. Briefly, pRS314 TEF Gga1
(KKD317) was isolated as described above. mRFP was cut from a previously isolated
vector, Ste2-mRFP (KKD145), and inserted into the vector using the BamHI and XhoI
restriction sites, then transformed into Stellar™ Competent Cells (Clontech, Cat. No.
636766) following the procedure detailed above. Colony PCR was performed to verify
mRFP insertion, then the plasmid was isolated from bacterial culture. A portion of the
bacterial strain was saved for future use (KKD319).
Yeast cultures in the mid log phase (OD600 0.6-0.8) were transformed following
the one-step transformation protocol (Chen et al., 1992). Plasmid insertion was confirmed
using yeast colony PCR.

Creation of Mutant Strains and Treatment with Myriocin
Mutant strains were created through knockout of genomic genes using
auxotrophic markers. Cells were cultured for 16-18 hours at 37 °C with shaking, or until
cultures reached mid log phase (OD600 0.6-0.8). Cells were imaged using a spinning disc
confocal microscope.
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The TEF promoter was added to pRS425 (KKD126) using the SacI and NotI
restriction sites, following the above protocol. The resulting plasmid was saved
(KKD233) and used for LCB1 insertion. LCB1 was copied by PCR from template
genomic DNA using primers KKP731 and KKP732, then inserted using the BamHI and
XhoI restriction sites, and saved as KKD281. The plasmid was used in yeast to create a
strain that overexpressed LCB1. An overexpression vector was also created for Erg4,
through addition of Erg4 to KKD233 using the BamHI and XhoI restriction sites, and
using primers KKP749 and KKP750 for amplification, according to the above protocol.
For myriocin treatment, wild type yeast (KKD1525) was cultured for 16-18 hours
at 30 °C with shaking, or until cultures reached early log phase (OD600 0.3-0.4).
Untreated cells were used as a control, while experimental cultures were treated with
myriocin to final concentrations of 0.0167 µg/ml, 0.167 µg/ml, 1.67 µg/ml, and 16.7
µg/ml. Treated cultures were grown for 2-2.5 hours at 30°C with shaking and then
imaged using confocal microscopy.

Cell Staining and Confocal Microscopy
For FM 4-64 staining, yeast wild-type and mutant strains were cultured for 16-18
hours at 30 °C with shaking, or until cultures reached mid log phase (OD600 0.6-0.8).
Cells were harvested using an Eppendorf tabletop centrifuge (Model No. 5418). Cells
were washed with cold synthetic defined (SD) complete media, then resuspended in cold
SD complete. FM® 4-64 dye (Thermo Fisher Scientific, Cat. No. T3166) was added to a
final concentration of 0.12 mM, and cells were incubated 10 minutes on ice. Cells were
harvested at 4 °C, then washed twice at 4 °C using ice cold SD complete. Cells were
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resuspended in cold SD complete, then kept on ice until imaging. Images were taken
using the spinning confocal microscope, within 7 minutes of removing cells from ice.
Cells showing FM® 4-64 staining that had already reached the vacuole were omitted
from quantification. Three sets of 30 cells each were quantified per strain, and statistical
analysis was performed to determine the mean, standard deviation, and p-value (using
Student’s t-test, comparing mutant strains to the control strain).
For actin staining, yeast wild type and mutant strains were cultured for 16-18
hours at 30 °C with shaking, or until cultures reached early log phase (OD600 of 0.3-0.6).
Cells were harvested by spinning at 1000 rpm for 10 minutes, the supernatant was
removed, then cells were resuspended in the appropriate media (SD complete or dropout
medias). Cells were fixed, with gentle agitation, for 60 minutes by the addition of
formaldehyde to the liquid media, with a final formaldehyde concentration of 4%.
Following fixation, cells were harvested, the supernatant was removed, and cells were
washed using 1X PBS, then resuspended in 1X PBS. Cells were sonicated on ice for two
pulses of 30 seconds each, using a Branson Sonifier® ultrasonic hydrogenator , allowing
time between pulses for the sample to cool. Following sonication, cells were harvested
and resuspended in 1X PBS. Cells were treated with Triton X-100 to permeabilize the
membrane and Texas Red to stain the actin fibers, at final concentrations of 0.1% and 3.3
μM, respectively. Cells were stained in the dark with gentle agitation for 20-30 minutes.
Following staining, cells were harvested, washed 3 times using 1X PBS, and imaged
using the spinning disc confocal microscope. Three sets of 30 cells each were quantified
per strain for presence or absence of visible actin cables, and statistical analysis was
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performed to determine the mean, standard deviation, and p-value (using Student’s t-test,
comparing mutant strains to the control strain).
All strains were grown to mid log phase (OD600 0.6-0.8) prior to visualization.
Visualization of fluorescently labeled cells was performed using an Olympus IX81
inverted system microscope equipped with a Yokogawa CSUXI spinning disk head.
Images were obtained using a 100X PlanApo oil immersion objective lens (numerical
aperture 1.4), and were captured using a Hamamatsu ImagEM CCD camera and 3i
Slidebook6 software. Simultaneous multi-color imaging was performed using a
Photometrics®DV2 image splitter.

Vps10 Transformation and Quantification
Competent cells were created from wild-type and mutant strains, to allow for
genomic transformation (Knop et al., 1999). Vps10-GFP PCR product was copied from
the template plasmid (primers KKP773 and KKP774) and verified by running on a 1%
agarose gel, then imaging to observe band presence. Competent cells were transformed
using the PCR product, then plated on selective media (Knop et al., 1999). Plates were
incubated at 30 °C in a stationary incubator until colonies were grown, then stored at 4°C.
To test for successful transformation, cells were checked for fluorescence using a
spinning confocal microscope. Successfully transformed colonies were selected for each
strain, and grown in selective liquid media for 16-18 hours at 30 °C with shaking. Cells
were imaged using a spinning disc confocal (3 sets of 30 cells per strain), and the number
of visible puncta were quantified.
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To track Vps10 puncta, cells were live imaged at 2 images/sec for 60 sec. For
each strain, 10 puncta that persisted for at least 15 seconds were found and tracked
manually using ImageJ software from first appearance until 15 seconds had elapsed.
Using Excel, the distance traveled between frames was calculated using the distance
formula, then summed to find the total distance traveled. Statistical analysis was
performed to determine the mean, and standard deviation, and Student’s t-test was used
to determine the p-value (control vs. mutant strains).

Statistical Analysis
For all experiments, quantification was performed by counting a minimum of 30
cells in three individual sets. Statistical analysis was performed to determine the mean,
and standard deviation of the three sets, and Student’s t-test (two-tailed, equal variances)
was used to determine the p-value (control vs. mutant strains). Statistical significance was
defined as a p-value of less than 0.05.

20

RESULTS

Importance of Membrane Lipid Balance in Proper Protein Recycling
Cholesterol concentration has been shown to play an important role in the
localization of SNAREs to the endosomes and Golgi (Enrich et al., 2015), and alterations
in membrane lipid composition have been shown to result in alterations in intracellular
trafficking, specifically in trafficking of Shiga toxin in mammalian cells (Kavaliauskiene
et al., 2014). This prompted us to investigate specifically the impacts of altering the
concencentration of three key membrane lipids (phospholipids, sphingolipids, and
ergosterol) on retrograde protein trafficking. To track proper functioning of this pathway,
I used GFP-tagged Snc1, which has been well established as a marker of protein
recycling (Hettema et al., 2003; Ma et al., 2016). Snc1 is a transmembrane protein that is
synthesized at the ER and then trafficked through the Golgi to the plasma membrane in
the secretory pathway (Lewis et al., 2000). Snc1 recyling involves three steps:
endocytosis; retrograde trafficking from the early endosomes to Golgi; and transport back
to the plasma membrane (Hettema et al., 2003). When the recycling pathway is
functional, the majority of the Snc1 protein is trafficked to the daughter bud (polarized),
and few internal puncta are seen (TerBush et al., 1996). I hypothesized that disturbance
of membrane lipid balance would likely result in defects in the recycling of Snc1,
resulting in loss of the polarized phenotype due to mistargeting of Snc1.
To test the effect of imbalance of PIP2, an important phospholipid, on Snc1 and its
recycling, I used mutant strains that caused overexpression or depletion of PIP2. In mss4ts
cells grown at elevated temperatures (37 °C), depletion of PIP2 is observed (Audhya and
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Emr, 2003), while single or double deletion of SJL1, SJL2, or SJL3 results in
accumulation of PIP2 (Guo et al., 1999). I hypothesized that imbalance of PIP2 would
result in Snc1 recycling defects. Consistent with my hypothesis, over or underexpression of phospholipids was found to inhibit proper GFP-Snc1 recycling. While
85.4% ± 6.7 of wild-type cells exhibited the normal, polarized GFP-Snc1 phenotype, the
percentage of cells with normal phenotype dropped to 31.3% ± 7.3 in sjl1∆ cells
(p<0.01), 30.3% ± 8.2 in sjl2∆ cells (p<0.01), and 4.0% ± 3.4 in mss4ts cells (p<0.001)
(Fig. 1A). Knockout of multiple genes in the phospholipid degradation pathway had even
lower levels of GFP-Snc1 polarization, with only 11.6% ± 8.1 of sjl1∆sjl2∆ cells
(p<0.001) and 0.7% ± 1.4 of sjl2∆sjl3∆ cells (p<0.001) showing the polarized phenotype
(Fig. 1B). The phospholipid mutant strains showed a variety of abnormal phenotypes
(Fig. 1A). In some strains, GFP-Snc1 was found at the membrane, but a loss of
polarization was observed, while mss4ts cells showed almost completely internal
accumulation of GFP-Snc1, mostly in vacuole-like membrane bound organelles, with a
lack of GFP-Snc1 at the membrane. Although strains with a single gene knocked out
(sjl1∆, sjl2∆) exhibited moderate defects in GFP-Snc1 localization, knockout of two
genes involved in phospholipid synthesis (sjl1∆sjl2∆, sjl2∆sjl3∆) led to more severe
defects.
To test the effect of altered sphingolipid levels, sphingolipid depletion was
achieved by treating cells with varying levels of the pharmacological agent myriocin,
which inhibits the first step in sphingolipid production (Miyake et al., 1995). The first
step in sphingolipid synthesis is catalyzed by the LCB1 gene product (Buede et al.,
1991), so sphingolipid overproduction was induced through expression of the LCB1 gene
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under the strong TEF promotor. Alteration of sphingolipid levels also led to defects in
GFP-Snc1 polarization (Fig. 2A and Fig. 2B). GFP-Snc1 was polarized in 86.3% ± 0.9 of
wild-type cells, while addition of the pharmacological agent myriocin resulted in lower
frequencies of polarization (Fig. 2B). GFP-Snc1 was polarized in 70.1% ± 2.6 (p<0.01),
41.2% ± 11.3 (p<0.05), 25.7% ± 3.8 (p<0.01), and 14.2% ± 4.3 (p<0.001) of cells treated
with 0.0167 µg/ml, 0.167 µg/ml, 1.67 µg/ml, and 16.7 µg/ml myriocin, respectively (Fig.
2A). With the exception of the TEF-LCB1 strain, sphingolipid mutants were broadly
depolarized, with even membrane staining, but showed few internal puncta. Although
even low levels of myriocin caused depolarization, higher levels led to more severe levels
of GFP-Snc1 depolarization (Fig. 2A). Interestingly, overproduction of Lcb1 under the
TEF promoter resulted in a phenotype similar to that seen in mss4ts cells, with severe
accumulation of GFP-Snc1 in internal puncta and a polarized phenotype being present in
only 7.0% ± 1.4 of cells (p<0.001), a very severe loss of GFP-Snc1 polarization (Fig. 2A,
B). These results indicate that sphingolipid balance is crucial for proper protein recycling.
The synthesis of ergosterol requires many steps, with some of the terminal steps
being catalyzed by the gene products of ERG3, ERG4, and ERG6, so knockout mutants
of these genes were used to deplete ergosterol levels in the cell (Lees et al., 1995).
Additionally, expression of ERG4 under the TEF promoter was used to produce an
overaccumulation of ergosterol. While alteration of ergosterol levels impacted GFP-Snc1
localization, the effect was not as severe as that seen in phospholipid or sphingolipid
imbalance cells. Compared to 87.5% ± 2.0 of wild type, ergosterol depletion mutants
showed decreased polarization, with 72.4% ± 1.7 of erg3∆ cells (p<0.001), 37.5% ± 5.7
of erg6∆ cells (p<0.01), 41.5% ± 4.1 of erg4∆erg6∆ cells (p<0.001) exhibiting the
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polarized phenotype. In TEF-ERG4 cells only 40.6% ± 4.4 of cells (p<0.001) exhibited a
polarized GFP-Snc1 phenotype (Fig. 3A and Fig. 3B). Based on these data, alteration of
ergosterol levels did not result in as strong of an impact on the localization of GFP-Snc1
as alteration of phospholipid and sphingolipid levels. Overall, however, imbalance of
each of the three membrane lipid classes resulted in defects of varying severity in
recycling of GFP-Snc1.
In order to exclude the possibility that the secretory portion of the recycling
pathway (from the Golgi to the plasma membrane) is impaired in membrane lipid
mutants, I introduced GFP-Snc1-PEM, a truncated form of Snc1 that can be transported
to the plasma membrane but cannot be endocytosed, to wild type and membrane lipid
mutants. Regardless of the strain, GFP-Snc1-PEM localization in mutant strains was
similar to wild type (Fig. 4). In all strains, GFP-Snc1-PEM showed even staining around
the plasma membrane, and a complete lack of internal puncta, indicating secretion from
the Golgi to the plasma membrane is normal.

Late Endosome to Golgi Trafficking of GFP-Snc1 is Hindered
Internal puncta of GFP-Snc1 were seen in a variety of lipid synthesis mutants, but
the internal accumulation of GFP-Snc1 was most pronounced in phospholipid mutants
(Fig. 1A). Therefore, I quantified the number of GFP-Snc1 puncta in wild type and
phospholipid phospholipid mutant strains. Compared to an average of 4.2 ± 0.5 puncta
per cell in wild type, phospholipid mutant strains showed increased numbers of GFPSnc1 puncta, with 8.5 ± 0.2 (p<0.001), 6.9 ± 0.2 (p<0.001), 10.2 ± 0.8 (p<0.01), and 8.5
± 1.35 (p<0.05) puncta per cell in sjl1∆, sjl2∆, sjl1∆ sjl2∆, and sjl2∆sjl3∆, respectively
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(Fig. 5). Based on these results, GFP-Snc1 is accumulated within the cell, indicating
trafficking from the early endosomes to the Golgi is hindered.
To test whether trafficking from the late endosomes to the Golgi was hindered in
phospholipid mutant strains, the late endosome marker Vps10-GFP was expressed in
these cells. Quantification of the average number of Vps10-GFP puncta present in wildtype and mutant strains revealed significant Vps10 accumulation in mutant strains.
Accumulation was also seen in bnr1∆ and bnr1bni1-12, which are difficient in the ability
to make actin cables (Buttery et al., 2007), indicating actin is important in the retrograde
trafficking process (Fig. 6A). Compared to an average of 6.1 ± 0.1 puncta per cell in
wild-type, sjl1∆, sjl2∆, sjl1∆sjl2∆, bnr1∆, and bnr1bni1-12 cells had an average of 11.5 ±
1.0 (p<0.01), 10.7 ± 0.9 (p<0.01), 12.3 ± 0.9 (p<0.01), 9.1 ± 0.3 (p<0.01), and 11.8 ±
0.8 (p<0.01) puncta per cell, respectively (Fig. 6B). Based on these results, membrane
lipid imbalance results in accumulation of Vps10 within the cell, indicating a defect in
late endosome to Golgi trafficking.

Membrane Lipid Imbalance Disrupts Actin Cable Formation
Alterations of the levels of PI4P within the endosomal membrane through the
action of VAP has been shown to indirectly alter nucleation of actin, through disrupting
functioning of the WASH complex (Dong et al., 2016). Based on this information, I
hypothesized that membrane lipid imbalance in general would likely interfere with proper
actin cytoskeleton/cable formation. To test for this, I fixed and stained wild-type and
membrane lipid imbalance cells. Compared to the high proportion of wild type cells
(62.3% ± 6.6) that exhibited visible actin cables (Fig. 7A), only 29.2 ± 6.0 of sjl1∆ cells
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(p<0.01), 26.3% ± 7.6 of sjl2∆ cells (p<0.01), 23.3% ± 7.4 of sjl1∆sjl2∆ cells (p<0.01),
16.5% ± 7.4 of sjl2∆sjl3∆ cells (p<0.01), and 28.6% ± 11.0 of mss4ts cells (p<0.05) (Fig.
7B) demonstared actin cables. Based on these results, the actin cytoskeleton is likely
highly fragmented in membrane-imbalance mutants.

Vps10-GFP Puncta Show Similar Mobility
Since the number of Vps10 puncta was elevated and actin cable defects were
observed in membrane lipid mutants, I wished to determine whether the mobility of the
puncta was impaired in mutant strains. To do this, I used time-lapse images and tracked
the movement of Vps10 puncta over time. Vps10 puncta in wild-type and membrane lipid
imbalance cells showed similar rates of movement, total distances traveled, and distance
from point of origin (Fig 8). In the total 15 seconds of tracking, Vps10-GFP puncta in
wild-type cells traveled an average total distance of 4.9 ± 0.9 µM, while puncta traveled
4.3 ± 0.7 µM in sjl1∆ cells, 5.0 ± 1.5 µM in sjl2∆ cells, and 4.7 ± 0.7 µM in sjl1∆sjl2∆
cells (Fig. 8). None of the mutant strains had statistically significantly different results
from the control strains. Based on these results, motility of puncta in these strains does
not appear to be impaired.
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DISCUSSION

Findings from my study have highlighted the importance of a correct balance of
sphingolipids, phospholipids, and ergosterol in the membrane in order to facilitate proper
retrograde trafficking of proteins in yeast. These findings have important implications for
the possible mechanisms of diseases that cause loss of membrane lipid homeostasis in
eukaryotic organisms. Additionally, my results indicate that membrane lipid imbalance
leads to the fragmentation of intracellular actin cables, and to the accumulation of cargoes
at the endosomes.

Lipid Imbalance and its Impact
Lipids have many biological roles, from roles in brain fuction and development
(Hellhammer et al., 2010; Liu et al., 2014; Nagai, 2012), to roles in cell cycle regulation
and cell signaling (Garcia-Gil et al., 2017; Ng et al., 2017). Additionally, lipids are key
components of membranes. The three main categories of membrane lipids,
phospholipids, sphingolipids, and cholesterol (ergosterol) have been shown to play
pivotal roles within the cell, especially in intracellular trafficking of a variety of materials
(Chen et al., 2016a; Cuesta-Geijo et al., 2015; Zhang et al., 2016). Since they are crucial
to the trafficking process, it is important for these three categories of lipids to be present
in optimal concentrations to allow proper function and maintainance of cellular functions.
The results of this study shed light on the crucial role of membrane lipid balance
in facilitating proper protein recycling. In particular, my results demonstrate the role of
phospholipid balance in retrograde trafficking from the early and late endosomes to the
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Golgi. While in a prior study sphingolipids were depleted using genetic manipulations
(Tani and Kuge, 2012), my work took an alternative approach to sphingolipid depletion
via use of the pharmacological agent myriocin to inhibit the pathway. This approach
allowed greater control of the experimental system, as well as providing insight into the
severity of recycling defects at a wide range of sphingolipid concentrations. Additionally,
through overexpression of Lcb1 under the TEF promotor, I was able to investigate the
impact of sphingolipid overaccumulation. My work and the work by Tani and Kuge
converged on the finding that sphingolipid imbalance results in defects in trafficking of
V-SNAREs, such as Snc1. However, their work overlooked the specific portion of the
pathway that was defective, while my work extended investigation to include this
question. Additionally, my results provide novel insight into the important role of the
balance of phospholipids and ergosterol in proper protein recycling, since imbalance
resulted in mistrafficking of Snc1 from the membrane of the daughter bud to either the
membrane of the mother cell or to puncta within the cell.
While imbalance of phospholipids and sphingolipids had a drastic effect on
proper protein recycling, ergosterol imbalance had a less severe impact. Although the
entire reason for this is not yet known, and requires further investigation, it is likely that
the severity of defects in lipid imbalance mutants depends on whether lipid precursors
with similar structures are present in the membrane to compensate for lack of the mature
form of the lipid. Since there are many genes involved in ergosterol synthesis, and the
deletion strains used in this study involved the terminal steps of the pathway, it is likely
that immature forms of ergosterol may be sufficient for proper functioning of the
recycling pathway. In contrast, since the synthesis of PIP2 involves fewer steps, there are
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likely no suitable precursors present to mitigate the loss of the mature form of the lipid,
leading to more severe defects in protein recycling in deletion strains. Similarly, since
sphingolipid synthesis was inhibited at the first step of the pathway, the downstream
species of the lipid would also be depleted, resulting in a lack of the lipids needed for
proper protein recycling.
The recycling pathway has three main steps: endocytosis, retrograde trafficking
from the endosomes to Golgi, and trafficking from the Golgi to the plasma membrane.
My results allowed me to determine the step of the pathway that was defective during
membrane lipid imbalance. Since Snc1 puncta were visible internally even in mutant
cells (Figs. 1-3), I concluded that membrane lipid imbalance does not completely hinder
the endocytic step of this pathway, even though the SJL genes and MSS4 have been
implicated in the endocytic process (De Camilli et al., 1996; Simonsen et al., 2001;
Stefan et al., 2002; Stefan et al., 2005). The presence of these intracellular puncta indicate
that, although endocytosis may be impaired, the endocytic pathway is not completely
inhibited in membrane lipid mutants. Additionally, through the use of the truncated Snc1PEM, it was verified that the secretory pathway, including Golgi to plasma membrane
trafficking, was functional in membrane lipid mutants (Fig. 4). Given that Snc1 is
shuttled through the early endosomes, and Snc1 puncta were accumulated in
phospholipid mutants, (Fig. 5), the defect in recycling of Snc1 is most likely due to
defects in early endosome to Golgi transport, rather than in the first or last segments of
the pathway, highlighting the important role of membrane lipid balance in this step of the
pathway. Based on my results, I formulated a model in which the secretory pathway is
normal, and endocytosis is not significantly impaired, but the trafficking between the
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early endosomes and Golgi is hindered, leading to accumulation of Snc1 primarily in the
cytoplasm (Fig. 9).
GFP-Snc1 was seen to accumulate intracellularly in large vacuole-like structures
in the mss4ts and TEF-LCB1 strains. While this finding requires additional investigation
using CellTracker™ Blue CMAC (7-amino-4-chloromethylcoumarin, ThermoFisher®)
staining to confirm that these accumulations are indeed found at the vacuole, it indicates
missorting of proteins to the degradation pathway, rather than the recycling pathway in
this strain. Interestingly, Snc1 accumulated in the lumen of these structures, rather than
being present at the rim of the vacuole. Normally, worn out or damaged proteins are
ubiquitinated, then sent to the vacuole for degradation through the action of the ESCRT
complex (Babst, 2011). Therefore, I speculate that in the mss4ts and TEF-LCB1 strains,
the ESCRT complex may be overactive, leading to excessive ubiquitination and targeting
of GFP-Snc1 for degradation, rather than recycling.
In light of the finding that trafficking from the early endosome to Golgi was
defective, I reasoned that the parallel trafficking pathway from the late endosomes to
Golgi was likely also defective in this scenario. I tested for defects in this pathway by
expressing Vps10-GFP in these cells. Since Vps10 is a late endosome marker, the
increased number of Vps10 puncta upon membrane lipid imbalance indicates that protein
trafficking to the Golgi is hindered, resulting in an excess of late endosomes. Based on
this, my model was refined to show hindrance of retrograde traffic from the late
endosomes to Golgi (Fig. 9). Although we have not tested the effect of sphingolipids and
ergosterol on late endosome to Golgi traffic, we would expect, based on the phospholipid
data, similar results and mechanism. To our knowledge, Vps10 has not previously been
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used in the study of membrane lipid imbalance to track retrograde trafficking between the
late endosomes and Golgi, and its use in the current study contributes to a greater
knowledge of the extent of trafficking defects caused by membrane lipid imbalance.

Mechanism of Protein Recycling Defects
Since defects in both the early and late endosome to Golgi pathways were
observed, the mechanism for the defect was investigated. The actin and microtubule
cytoskeletons are important for intracellular trafficking, with the assistance of motor
proteins such as myosin and dynein. In mammalian cells, microtubules have been shown
to be important in endosome to Golgi traffic (Itin et al., 1999), and actin has also been
implicated in this process (Loubery et al., 2008). Vesicles are transported between
organelles along cytoskeletal fibers including actin fibers (Gunning et al., 2015).
Therefore, the integrity of the actin network was of particular interest. Interestingly,
phospholipid mutants were found to have disrupted cable systems, which is likely part of
the mechanism of the defects observed in these strains. When actin cables are disturbed,
intracellular trafficking would also be disturbed, leading to improper protein
accumulation in the cytoplasm. When the membrane lipid balance is normal, the actin
cables are intact, and retrograde traffic of Snc1 from the early endosomes to the Golgi, as
well as retrograde traffic of Vps10 from the late endosomes to the Golgi, is normal (Fig.
10A). When there is an imbalance in the membrane lipids, the actin cables are disrupted,
leading to a hindrance in retrograde traffic and accumulation of Snc1 and Vps10 in the
cytoplasm (Fig. 10B). Currently, the mechanism by which membrane lipid imbalance
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disrupts actin cables is not yet known, and further studies are required to elucidate the
interactions causing this disturbance.
Although the mobility of Vps10-GFP puncta was not found to be significantly
different in wild type and phospholipid mutant strains, the speed at which the puncta
disappeared from the focal plane varied significantly. While puncta in phospholipid
mutants persisted for extended periods of time, the puncta in wild-type cells were much
more dynamic, and disappeared after much briefer periods of time. Since the puncta were
moving through the Z plane, accurate tracking of their mobility was not possible, and my
results underestimate the true mobility of puncta in wild-type cells. Ideally, 4D imaging
would be used to track these particles in the future, leading to greater insight on the
impacts of membrane lipid imbalance on protein trafficking.
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Table 1. Yeast strains used in this study.
Strain number Source

Genotype

KKY 0002

Invitrogen

MATa his3∆1 leu2D met15∆ ura3∆

KKY 0038

This study

MATα bnr1∆::KanR his3∆ leu2∆ lys2∆ ura3∆

KKY 0040

This study

MATα bnr1∆::KanR bni1-11::URA3 his3 leu2 lys2 ura3

KKY 0074

This study

MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ERG3::KanMX6

KKY 0075

This study

MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ERG6::KanMX6

KKY 0197

Invitrogen

MATα his3∆leu2∆lys2∆ura3∆

KKY 0352

This study

MATα his3∆ura∆leu∆trp∆lys∆ VPS1::KanMx6

KKY 0419

This study

MATα leu2-3,112 ura3-52 his3-∆200 trp1-∆901 lys2801 suc2-∆9, SJL2∆::HIS3, SJL3∆::TRP1

KKY 0420

This study

MATa leu2-3,112 ura3-52 his3-∆200 trp1-∆901 lys2801 suc2-∆9, SJL1∆::HIS3, SST1∆::URA3

KKY 0421

This study

MATa leu2-3,112 ura3-52 his3-∆200 trp1-∆901 lys2801 suc2-∆9, SJL2∆::HIS3, SST1∆::URA3

KKY 0422

This study

MATa leu2-3,112 ura3-52 his3-∆200 trp1-∆901 lys2801 suc2-∆9, SJL1∆::HIS, SJL2∆::HIS3, SST1∆::URA3

KKY 0423

This study

MATα leu2-3,112 ura3-52 his3-∆200 trp1-∆901 lys2801 suc2-∆9, MSS4∆::HIS3 [CEN LEU2 mss4 ts]

KKY 0818

This study

MATa his∆trp∆met∆lys∆, ERG4::HIS, ERG6::KanMX6

KKY 0819

This study

MATa his∆trp∆met∆, ERG4::HIS, ERG6::KanMX6

KKY 1415

This study

KKY 0075 (pRS416-GFP-Snc1)

KKY 1416

This study

KKY 0074 (pRS416-GFP-Snc1)

KKY 1417

This study

KKY 0818 (pRS416-GFP-Snc1)

KKY 1444

This study

KKY 0002 (pRS416-GFP-Snc1)

KKY 1446

This study

KKY 0423 (pRS416-GFP-Snc1)

KKY 1447

This study

KKY 0607 (pRS416-GFP-Snc1)

KKY 1448

This study

KKY 0420 (pRS315-GFP-Snc1)
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Table 1, continued.
Strain number Source

Genotype

KKY 1449

This study

KKY 0421 (pRS315-GFP-Snc1)

KKY 1450

This study

KKY 0422 (pRS315-GFP-Snc1)

KKY 1451

This study

KKY 0419 (pRS416-GFP-Snc1)

KKY 1457

This study

KKY 0002 (pRS416-GFP-Snc1-PEM)

KKY 1525

This study

KKY 0002 (pRS315-GFP-Snc1)

KKY 1565

This study

KKY 0423 (pRS416-GFP-Snc1-PEM)

KKY 1573

This study

KKY 0417 (pRS416-GFP-Snc1-PEM)

KKY 1574

This study

KKY 0419 (pRS416-GFP-Snc1-PEM)

KKY 1575

This study

KKY 0607 (pRS416-GFP-Snc1-PEM)

KKY 1612

This study

KKY 1444 (pRS425-TEF-LCB1)

KKY 1613

This study

KKY 0075 (pRS416-GFP-Snc1-PEM)

KKY 1614

This study

KKY 0074 (pRS416-GFP-Snc1-PEM)

KKY 1615

This study

KKY 1525 (pRS425-TEF-Erg4)

KKY 1786

This study

KKY 420 Vps10-GFP-Trp

KKY 1787

This study

KKY 421 Vps10-GFP-Trp

KKY 1788

This study

KKY 422 Vps10-GFP-Trp

KKY 1820

This study

KKY 197 Vps10-GFP-His3MX6
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Table 2. Bacterial plasmids used in this study.
Plasmid Number Source

Plasmid Name

KKD 0061

(Furuta et al., 2007)

pRS416-GFP-Snc1

KKD 0062

(Furuta et al., 2007)

pRS416-GFP-Snc1-PEM

KKD 0064

(Furuta et al., 2007)

pRS315-GFP-Snc1

KKD 0094

Phil Hieter

pRS314

KKD 0126

Phil Hieter

pRS425

KKD 0145

Hokkaido University

pRS416-TEF-Ste2-mRFP

KKD 0233

This study

pRS425-TEF

KKD 0281

This study

pRS425-TEF-LCB1

KKD 0283

This study

pRS425-TEF-Erg4

KKD 0293

This study

pRS314-TEF

KKD 0317

This study

pRS314-TEF-Gga1

KKD 0319

This study

pRS314-TEF-Gga1-mRFP
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Table 3. Oligonucleotides used in this study.
Primer
Number

Primer Name

Sequence

KKP726

Gga1 in p314 TEF,
reverse

5’-GACATGGATCCTATTGTGGGCAAACTGGT
CGTGC-3’

KKP731

LCB1 in PRS425,
forward

5’-CACTGGATCCATGGCACACATCCCAGAGG
TTTTACC-3’

KKP732

LCB1 in PRS425,
reverse

5’-CATCCTCGAGTTATTTATTAGATTCTTGGC
AACAGGCAAGGATGG-3’

KKP749

Erg4 in TEF PRS425, 5’-CACTGGGATCCATGGCAAAGGATAATAGT
forward
GAGAAGCTGCAGGT-3’

KKP750

Erg4 in TEF PRS425, 5’-CACTGCTCGAGCTAGAAAACATAAGGAAT
reverse
AAAGACGTAAGGGCA-3’

KKP773

Vps10 GFP tagging,
forward

5’-GAAGGAAATGAGGAAAACATCGACAGGC
CTGATTCTACAGCGCCATCTAACGAAAACCA
GCGGATCCCCGGGTTAATTAA-3’

KKP774

Vps10 GFP tagging,
reverse

5’-CTGCTCGTTTTTGTTTATGAAAAGTATATG
GAATTATCTACTCTATGTAAAGTAATCTCTG
AATTCGACTCGTTTAAAC-3’

KKP797

Gga1 in p314 TEF,
forward

5’-GACAGCGGCCGCATGCCACAAAGAATTGA
GCTTACCTCCGAA-3’
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Figure 1. Characterization of the localization of GFP-Snc1 in wild type and phospholipid
mutant cells A) Representative images of wild type (positive control) and phospholipid
mutant cells. mss4ts cells were grown at an elevated temperature (37°C) B) Percent of
cells showing GFP-Snc1 polarization. Quantification was performed on 3 sets of 30 cells
each. * p<0.05, ** p<0.01, *** p<0.001.
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Figure 2. Characterization of the localization of GFP-Snc1 in wild-type, sphingolipid
mutant and sphingolipid-overexpressing cells A) Representative images of wild-type and
sphingolipid vand sphingolipid-overexpressing cells. B) Percent of cells showing GFPSnc1 polarization. Quantification was performed on 3 sets of 30 cells each. * p<0.05, **
p<0.01, *** p<0.001.
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Figure 3. Characterization of the localization of GFP-Snc1 in wild-type, ergosterol
mutant and ergosterol-overexpressing cells A) Representative images of wild-type,
ergosterol mutant and ergosterol-overexpressing cells. B) Percent of cells showing GFPSnc1 polarization. Quantification was performed on 3 sets of 30 cells each. * p<0.05, **
p<0.01, *** p<0.001
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Figure 4. Localization of Snc1-GFP-PEM in wild-type and membrane lipid mutants.
Wild-type and mutant strains exhibit similar phenotypes, indicating the secretory
pathway is normal in membrane lipid mutants.
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Figure 5. GFP-Snc1 puncta accumulate in phospholipid mutants. A) Representative
images of GFP-Snc1 puncta in wild type and membrane lipid mutants. B). Quantification
of average number of GFP-Snc1 puncta per cell in wild type and phospholipid mutant
strains. * p<0.05, ** p<0.01.
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Figure 6. Vps10 puncta accumulate in membrane lipid mutants. A). Representative
images of GFP-Vps10 localization in wild-type and mutant strains. B). Quantification of
number of Vps10-GFP puncta present in wild type and mutant strains, 3 sets of 30 cells
each. ** p<0.01.
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Figure 7. Actin cables are diminished in membrane lipid mutants. A). Representative
images of cells stained with rhodamine-phalloidin dye to detect the presence of actin
cables. B). Quantification of percent of cells with visible actin cables, 3 sets of 30 cells
each. ** p<0.01.
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Figure 8. Average distance traveled by Vps10-GFP puncta. Cells were live-imaged at 2
frames/sec for 60 sec. Puncta that appeared and persisted for at least 15 seconds were
manually tracked using ImageJ software, from the time of appearance for 15 seconds. In
each frame, the location of the dot was marked, and Excel was used to calculate total
distance traveled over 15 seconds. There was no significant difference between distance
traveled by Vps1-GFP dots in the control and mutant strains.
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Figure 9. Model of Snc1 trafficking in yeast. In the synthetic pathway (black arrows),
Snc1 is synthesized at the endoplasmic reticulum, then trafficked through the early and
late Golgi to the plasma membrane. In the recycling pathway, Snc1 is endocytosed to the
early endosomes, then trafficked to the Golgi (retrograde trafficking) and then back to the
plasma membrane. In membrane lipid imbalance, there is a defect in retrograde
(endosome to Golgi) trafficking, which results in accumulation of Snc1 at the early
endosomes. The parallel pathway from the late endosomes to the Golgi is also defective,
resulting in accumulation of Vps10 at the late endosomes.
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Figure 10. Model of trafficking defects observed due to membrane lipid imbalance. A) In
wild-type cells, traffic is normal, with Snc1-carrying vesicles being transported along
actin cables from the early endosomes to the Golgi, and Vps10-carrying vesicles being
transported from the late endosomes to the Golgi. B) In membrane lipid imbalance cells,
actin cables are depleted, and traffic of Snc1- and Vps10-carrying vesicles from the early
and late endosomes, respectively, to the Golgi is hindered. This results in protein
accumulation at the endosomes.

59

